Ever since the advent of DSOs back in the early 1990's, the industry has relentlessly pursued the holy grail of increasing clinical productivity and EBITDA margins. After all, that's how private equity transaction valuations are made.

Dental sleep medicine presents a significant potential growth area for DSOs. However, an operationally viable way to integrate this specialty has long illuded DSO leaders. Until now.

In this white paper, you'll learn about new technology making dental sleep medicine feasible and see financial models that illustrate return on investment.